CDT Equity Inc. (CDTTW)

Current Report Filed: 2026-05-15

CDT has amended its equity line of credit (ELOC) facility to increase the gross purchase price per closing to $510,000, providing greater capital raising flexibility without requiring investor consent.
The company extended the Adjustment Period under the Purchase Agreement until the institutional investor completes all share sales, suggesting potential liquidity constraints or market absorption concerns.
A significant cash retention concession was granted through the Note Amendment, allowing CDT to retain 90% of proceeds from financing transactions (up from an implied lower percentage) with only 10% going toward debt repayment, indicating financial stress and negotiated relief.

Insider Trading Filed: 2026-05-14

CEO Andrew Regan exercised 147,401 pre-funded warrants on March 24, 2026, converting them to common stock at minimal cost ($0.0001 exercise price), indicating confidence in the company's direction.
Regan made a substantial open-market purchase of 100,000 shares on May 13, 2026 at $1.90 per share ($190,000 total investment), demonstrating significant insider confidence in the stock's valuation and near-term prospects.
The CEO's total beneficial ownership grew to approximately 256,393 shares through indirect holdings via Corvus Capital Ltd. and Manoira Corporation, though he ceased being a 10% owner as of February 19, 2026.
The company executed a 1-for-25 reverse stock split on March 26, 2026, which typically indicates efforts to meet exchange listing requirements or improve stock price perception following a period of weakness.

Current Report Filed: 2026-04-27

Board leadership transition with Chele Chiavacci Farley appointed as Board chairperson following Freda Lewis-Hall's resignation due to family health reasons; this is a routine succession with no operational disagreements noted.
Ulrik Olsen appointed as director with significant commercial property industry expertise and managing director roles at multiple companies, bringing relevant experience to CDT's portfolio given the company's 20% stake in Sarborg Limited.
New director Olsen holds approximately 7.84% ownership in Sarborg Ltd., creating a potential related-party interest that investors should monitor for conflicts of interest despite disclosed independence determination.
Board committee restructuring maintains governance continuity with Simon Fry taking over as Audit Committee chair, while Farley retains Audit Committee membership despite her new chairperson responsibilities.

Annual Report Filed: 2026-04-15

CDT Equity Inc. (CDTTW) filed its 2025 annual report (10-K) on 2026-04-15, providing financial and operational details for the fiscal year ended 2025-12-31.
The company has outstanding redeemable warrants that are each exercisable for one share of common stock at an exercise price of $11.50.
CDT Equity entered into several related party transactions during 2025, including the sale and purchase of common stock and prefunded warrants.

Current Report Filed: 2026-03-25

CDT Equity Inc. has announced a 1-for-25 reverse stock split, which will reduce the number of outstanding shares and potentially increase the stock price.
The reverse stock split is expected to become effective on March 26, 2026, and the company's common stock will begin trading on a split-adjusted basis on March 27, 2026.
No fractional shares will be issued as a result of the reverse split, and stockholders of record who would otherwise be entitled to receive a fractional share will receive a cash payment instead.

Current Report Filed: 2026-03-18

The company is seeking shareholder approval to issue additional shares of common stock, which could dilute existing shareholders.
The company plans to pursue a reverse stock split, which could improve the stock's trading price and liquidity.
The company is proposing to redomicile from Delaware to the Cayman Islands, which could impact shareholder rights and tax implications.

Current Report Filed: 2026-03-09

CDT Equity Inc. has amended its existing equity line of credit (ELOC) with an institutional investor, lowering the floor price to $0.60 per share, which could increase the potential maximum number of shares issuable under the ELOC.
The company has issued a senior secured convertible promissory note with a principal amount of up to $555,556, which is convertible into common stock subject to shareholder approval.
The convertible note is secured by certain company assets and further secured by a guaranty agreement, providing additional assurances for the investor.

Current Report Filed: 2026-02-24

CDT Equity Inc. has acquired a 20% stake in Sarborg Limited, a Cayman Islands company, for a consideration of shares of its common stock and pre-funded warrants.
The company has also extended its consulting agreement with NJS Foresight Bio-Advisory, LLC for an additional 12 months, with a one-time fixed retainer payment in the form of shares of its common stock.
The transactions indicate that CDT Equity Inc. is actively pursuing growth opportunities through strategic investments and partnerships.

Current Report Filed: 2026-01-02

CDT Equity Inc. entered into two material consulting agreements with Thesprogen, PC and NJS Foresight Bio-Advisory, LLC to optimize its pre-clinical development and out-licensing strategy for its asset portfolio.
As consideration for the consulting agreements, CDT issued a total of 213,288 shares of its common stock valued at the closing price immediately preceding the execution of the agreements.
The NJS agreement includes a one-time fixed retainer of $150,000 and an 8% commission fee on the total announced value of any out-licensing transactions, partnerships or definitive agreements executed during the 12-month term.

Important Information